LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K062558
    Device Name
    MESOSFOL SURGICAL FILM
    Manufacturer
    BIOMET MANUFACTURING CORP.
    Date Cleared
    2007-06-20

    (294 days)

    Product Code
    FTM
    Regulation Number
    878.3300
    Type
    Traditional
    Panel
    General & Plastic Surgery
    Reference & Predicate Devices
    K031955,K042811
    Why did this record match?
    Device Name :

    MESOSFOL SURGICAL FILM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Mesofol® Surgical Sheet is indicated when temporary wound support is required to reinforce soft tissues where weakness exists, or in conjunction with hernia repair or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result. The resorbable protective sheet minimizes tissue attachment to the device in case of direct contact with the viscera.

    Device Description

    Mesofol® Surgical Sheet is an implantable, resorbable, polymeric surgical sheet manufactured by ITV Denkendork in Germany. Mesofol® Surgical Sheet is offered in various sizes 4cm x 4cm to 20cm x 25cm and is 40jum in thickness. Mesofol® Surgical Sheet can be cut into different sizes and shapes by the end user. The sheet can be fixed with degradable suture material in situations where the anatomical conditions of the wound area are not suited to adequately fix the sheet. Mesofol® Surgical Sheet is manufactured from a lactide-caprolactone copolymer. Mesofol® Surgical Sheet is chemically broken down by hydrolytic cleavage of the polymer, giving rise to three monomers: 6-hydroxycaproic acid, D-lactic acid, and Llactic acid. 6-Hydroxycaproic acid is broken down to acetyl-CoA units via ß-oxidation (fatty acid metabolism) for further dearadation via the Krebs cycle. L-Lactate is broken down in the Cori cycle (lactic acid cycle) to qlucose via pyruvate. These two monomers are thus degraded to products that are physiologically metabolized by the body.

    AI/ML Overview

    The provided text does not contain information about acceptance criteria for device performance, a study to prove meeting acceptance criteria, or any of the other specific questions laid out in the request regarding sample sizes, expert involvement, or ground truth.

    The document is a 510(k) summary for the Mesofol® Surgical Sheet, focusing on establishing substantial equivalence to predicate devices based on device description, intended use, and non-clinical testing (biocompatibility). It explicitly states: "Clinical Testing: None provided as a basis for substantial equivalence."

    Therefore, I cannot extract the requested information from the provided text.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1